Medical Condition News

RSS

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.

22 Sep 2010

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

$Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures$

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

Spanish researchers have confirmed there is a genetic risk factor for osteoporosis and bone fractures. Although more studies are still needed, these findings will make it possible to take preventive measures.

22 Sep 2010

Study finds no benefit from self-management counseling in patients with heart failure

Patients with mild to moderate heart failure who received educational materials and self-management counseling in an attempt to improve adherence to medical advice did not have a reduced rate of death or hospitalization compared to patients who received educational materials alone, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

Feeding Your Kids challenges families to take 42-day program to combat childhood obesity

Feeding Your Kids is proud to announce its participation in the Clinton Global Initiative Annual Meeting taking place from September 20-23 in New York City, and bringing together Initiative members from around the world to address a variety of global problems through tangible Commitments to Action. In honor of the annual meeting and Childhood Obesity Awareness Month, Feeding Your Kids is challenging families nationwide to take its 42-day program and change the way they feed their families.

22 Sep 2010

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

St. Jude Medical, Inc., a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device Registry. The results reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures.

22 Sep 2010

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).

22 Sep 2010

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.

22 Sep 2010

Protein zyxin necessary for maintenance and repair of cell's cytoskeleton

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.

22 Sep 2010

Researchers receive $634,000 grant to study environmental factors, MS progression

A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.

22 Sep 2010

UT MD Anderson Cancer Center aims to reduce tobacco use among at-risk youths in SE Texas

The University of Texas MD Anderson Cancer Center is reaching out to southeast Texas via an interactive, arcade-style video game aimed at reducing tobacco use among at-risk teens and adolescents.

22 Sep 2010

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

The first in-human study of a robotically assisted percutaneous coronary intervention system demonstrated that the technique was safe and feasible. The results of the study were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

22 Sep 2010

AACR to host fourth International Conference on Molecular Diagnostics

The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

22 Sep 2010

Pancreas releases new NANETS guidelines on rare group of cancers

Neuroendocrine tumors (NETs) are a group of rare cancers that pose unique challenges in diagnosis and treatment. In a recent issue of Pancreas, official journal of the American Pancreatic Association, presents the newly developed consensus guidelines of the North American Neuroendocrine Tumor Society (NANETS).

22 Sep 2010

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.

22 Sep 2010

Study: College women with heavy roommates gain less weight during freshman year

A new University of Michigan study finds that college women with roommates who weigh more than average gain less weight during their freshman year than women with slimmer roommates: half a pound versus 2.5 pounds.

22 Sep 2010

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

22 Sep 2010

JHS conference focuses on future research directions to eliminate health disparities

The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease, stroke, diabetes, and other important diseases in African-Americans.

22 Sep 2010

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.

22 Sep 2010

New findings could impact diagnosis and treatment of ADHD and alcoholism

Impulsive behaviour can be improved with training and the improvement is marked by specific brain changes, according to a new Queen's University study.

22 Sep 2010

Medical Condition News

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

Study finds no benefit from self-management counseling in patients with heart failure

Feeding Your Kids challenges families to take 42-day program to combat childhood obesity

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

Protein zyxin necessary for maintenance and repair of cell's cytoskeleton

Researchers receive $634,000 grant to study environmental factors, MS progression

UT MD Anderson Cancer Center aims to reduce tobacco use among at-risk youths in SE Texas

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

AACR to host fourth International Conference on Molecular Diagnostics

Pancreas releases new NANETS guidelines on rare group of cancers

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Study: College women with heavy roommates gain less weight during freshman year

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

JHS conference focuses on future research directions to eliminate health disparities

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

New findings could impact diagnosis and treatment of ADHD and alcoholism

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Latest News